Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
safimaltib (JNJ-6633)
i
Other names:
JNJ-6633, JNJ 67856633, JNJ-67856633
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
J&J
Drug class:
MALT1 protein inhibitor
Related drugs:
‹
ONO-7018 (1)
MPT-0118 (0)
SGR-1505 (0)
ONO-7018 (1)
MPT-0118 (0)
SGR-1505 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
CARD11 mutation
Diffuse Large B Cell Lymphoma
CARD11 mutation
Diffuse Large B Cell Lymphoma
JNJ-6633
Sensitive: D – Preclinical
JNJ-6633
Sensitive
:
D
JNJ-6633
Sensitive: D – Preclinical
JNJ-6633
Sensitive
:
D
CD79B mutation
Diffuse Large B Cell Lymphoma
CD79B mutation
Diffuse Large B Cell Lymphoma
JNJ-6633
Sensitive: D – Preclinical
JNJ-6633
Sensitive
:
D
JNJ-6633
Sensitive: D – Preclinical
JNJ-6633
Sensitive
:
D
CD79B mutation
Diffuse Large B Cell Lymphoma
CD79B mutation
Diffuse Large B Cell Lymphoma
JNJ-6633 + JNJ-4681
Sensitive: D – Preclinical
JNJ-6633 + JNJ-4681
Sensitive
:
D
JNJ-6633 + JNJ-4681
Sensitive: D – Preclinical
JNJ-6633 + JNJ-4681
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login